Omaha, NE – Streck will sponsor a webinar on “Controlling Pre-Analytical Variables in Liquid Biopsy Assay Development.” The free webinar, hosted by Cambridge Healthtech Institute, will be from 11 a.m. to noon EST on Thursday, Jan. 26.
Biomarkers such as circulating nucleic acids and circulating tumor cells have become an increasingly important source for liquid biopsy assays. Successful detection of biomarkers is dependent on controlling pre-analytical variables, such as peripheral blood collection, processing and shipment and storage methods. Learn how Streck blood collection tubes can help preserve valuable samples for liquid biopsy assay development.
Participants will learn about common pre-analytical variables in sample collection and how it can negatively impact assay development; how Streck Cell-Free DNA BCT® can help control pre-analytical variables; information on Streck’s new plastic blood collection tube; and how Sysmex Inostics has incorporated Cell-Free DNA BCT into its assays.
Dr. Carissa Moore, Ph.D., R&D Scientific Manager, Immunology and Biomarkers Division, Streck, will present the pre-analytical variables in liquid biopsy assay development and a solution for stabilizing cell-free DNA in patient samples that takes collection, storage and transportation issues out of the equation. Dr. Moore oversees Streck’s development of clinical flow cytometry controls and blood collection tubes.
Also speaking will be Inga Medina Diaz, M.Sc., Research Associate Preanalytics, Research & Development Service Laboratories, Sysmex Inostics GmbH. Her areas of expertise include blood collection tubes, storage and shipment, as well as plasma preparation conditions, DNA extraction methods, qPCR analysis and BEAMing technology. She presented data on Streck cfDNA blood collection tubes for liquid biopsy testing at the CNAPS congress (Berlin, 2015) and the AACR Annual Meeting (New Orleans, 2016).
Cell-Free DNA BCT is for Research Use Only. Not for use in diagnostic procedures in the U.S.
Register by clicking here: Streck-sponsored webinar.
About Streck, Inc.
Established in 1971, Streck develops and manufactures products for clinical and research laboratories. Streck’s passion for innovation, quality and service has allowed the organization to become a world leader in the development of quality control and diagnostic products that help laboratories ensure accurate and timely results for patients. Streck offers the industry’s leading automated erythrocyte sedimentation rate instrument and is a worldwide supplier of blood collection tubes that standardize methods for sample collection, stabilization and transportation. Expanding product lines include flow cytometry, body fluids and urinalysis with emerging products being developed for the burgeoning field of molecular diagnostics. For more information, visit www.streck.com.